64 related articles for article (PubMed ID: 7755771)
1. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke.
Koren MJ; Bryant B; Hilton TC
N Engl J Med; 1995 May; 332(18):1237; author reply 1237-8. PubMed ID: 7755771
[No Abstract] [Full Text] [Related]
2. Cholesterol emboli associated with warfarin treatment.
Moll S; Huffman J
Am J Hematol; 2004 Oct; 77(2):194-5. PubMed ID: 15389900
[No Abstract] [Full Text] [Related]
3. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke.
Kistler JP
N Engl J Med; 1995 May; 332(18):1238. PubMed ID: 7700327
[No Abstract] [Full Text] [Related]
4. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke.
Di Tullio MR; Sacco RL; Homma S
N Engl J Med; 1996 Nov; 335(19):1464; author reply 1464-5. PubMed ID: 8927084
[No Abstract] [Full Text] [Related]
5. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging.
Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Higashi K; Kihara T; Sawada S; Iwamoto N; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
J Am Coll Cardiol; 2005 Mar; 45(5):733-42. PubMed ID: 15734619
[TBL] [Abstract][Full Text] [Related]
6. Blue toe syndrome caused by cholesterol crystal embolisation in a patient with warfarin use.
Kano Y; Shigehara Y
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37798039
[No Abstract] [Full Text] [Related]
7. Significance of aortic atheroma in elderly patients with ischemic stroke. A hospital-based study and literature review.
Sharifkazemi MB; Aslani A; Zamirian M; Moaref AR
Clin Neurol Neurosurg; 2007 May; 109(4):311-6. PubMed ID: 17250954
[TBL] [Abstract][Full Text] [Related]
8. Late onset purple toe syndrome with warfarin successfully treated with fondaparinux.
Rindone JP; Mellen CK; Eliason JD
Am J Ther; 2011 Nov; 18(6):e277-9. PubMed ID: 20535004
[TBL] [Abstract][Full Text] [Related]
9. Aortic atheroma. An unknown source of ischemic stroke.
Accadia M; Ascione L; Tartaglia PF; Guarini P; De Michele M; Muto C; Sacra C; Tuccillo B
Minerva Cardioangiol; 2002 Feb; 50(1):53-61. PubMed ID: 11830719
[TBL] [Abstract][Full Text] [Related]
10. Aortic atherosclerotic disease and stroke.
Kronzon I; Tunick PA
Circulation; 2006 Jul; 114(1):63-75. PubMed ID: 16818829
[No Abstract] [Full Text] [Related]
11. [Blue toe syndrome--a rare but possible complication of anticoagulant therapy].
Varis J; Kuusniemi K; Heiro M; Järveläinen H
Duodecim; 2011; 127(11):1154-7. PubMed ID: 21755807
[TBL] [Abstract][Full Text] [Related]
12. [Atherosclerosis of the aortic arch: a possible new source of cerebral embolism].
Amarenco P; Cohen A
Ann Cardiol Angeiol (Paris); 1994 May; 43(5):278-81. PubMed ID: 8074423
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol embolization to bladder in setting of transient ischemic attack and hematochezia: an unusual presentation of cholesterol embolization syndrome.
Black CE; Cold CJ; Unwala DJ
Urology; 2010 Oct; 76(4):791-3. PubMed ID: 20800883
[No Abstract] [Full Text] [Related]
14. Aortic plaque imaging and monitoring atherosclerotic plaque interventions.
Momiyama Y; Fayad ZA
Top Magn Reson Imaging; 2007 Oct; 18(5):349-55. PubMed ID: 18025989
[TBL] [Abstract][Full Text] [Related]
15. [A cholesterol embolism during heparin treatment].
López Pardo F; González Barrero A; Serrano Castro V; Andreu Alvarez J; Navarrete Ortega M; Burgos Cornejo J
Rev Esp Cardiol; 1993 Nov; 46(11):758-60. PubMed ID: 8290779
[TBL] [Abstract][Full Text] [Related]
16. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy.
Lima JA; Desai MY; Steen H; Warren WP; Gautam S; Lai S
Circulation; 2004 Oct; 110(16):2336-41. PubMed ID: 15477398
[TBL] [Abstract][Full Text] [Related]
17. [1-ethoxysilatrane--an inhibitor of the development of experimental atherosclerotic lesion of the aorta].
Konova NS; Pertsovskiĭ AI; Voronkov MG
Dokl Akad Nauk SSSR; 1984; 276(3):757-9. PubMed ID: 6468268
[No Abstract] [Full Text] [Related]
18. Disappearance of a large intraaortic mass in a patient with prior systemic embolization.
Freedberg RS; Tunick PA; Culliford AT; Tatelbaum RJ; Kronzon I
Am Heart J; 1993 May; 125(5 Pt 1):1445-7. PubMed ID: 8480606
[No Abstract] [Full Text] [Related]
19. Marked regression of aortic plaque by intensive cholesterol-lowering therapy.
Sakamoto J; Izumi C; Takahashi S; Hashiwada S; Nakajima S; Nishiga M; Yamao K; Hanazawa K; Miyake M; Tamura T; Kondo H; Motooka M; Kaitani K; Nakagawa Y
J Atheroscler Thromb; 2011; 18(5):421-4. PubMed ID: 21242651
[TBL] [Abstract][Full Text] [Related]
20. [Use of rheopolyglucin in atherosclerotic lesion of the abdominal aorta and its branches].
Nozdrachev IuI
Khirurgiia (Mosk); 1974 May; (5):90-4. PubMed ID: 4457695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
